STUDY

DRUGS

DOSE AND DURATION

BEFORE TREATMENT

AFTER TREATMENT

P VALUE

Cemil kaya (2009)

Atorvastatin

20 mg OD *3 months

14.3 ± 2.9

10.6 ± 1.7

<0.01

Harmanci (2013)

Simvastatin

20 mg OD *3 months

13.6 ± 2.1

11.1 ± 1.9

<0.05

Yilmaz (2005)

EE-DSRP + spironolactone

3 mg/30 µg + 100 mg OD *6 months

13.1 ± 5.2

17.6 ± 5.3

<0.05

Cagnacci (2006)

Rosiglitazone

4 mg OD*3 months

13.94 ± 6.72

13.2 ± 5.88

NS

Gul OB (2008)

EE/DSG

40/30 µg + 25/125 mg OD*6 months

9.54 ± 0.7

9.8 ± 0.6

NS

EE/CPA

35 µg + 2 mg OD *6 months

9.8 ± 1.9

7.9 ± 0.9

<0.05

EE/CPA

35 µg + 2 mg OD *3 months

55.97 ± 16.04

54.03 ± 16.15

0.001